Suchergebnisse - "Neurath, Markus F"

PubPharm (23)

1

Immune cell trafficking and retention in inflammatory bowel disease : mechanistic insights and therapeutic advances

enthalten in: Gut | 2019

von Zundler, S. | Becker, E. | Schulze, L. | +1

2

Mechanisms of molecular resistance and predictors of response to biological therapy in inflammatory bowel disease

enthalten in: The lancet. Gastroenterology & hepatology | 2018

von Atreya, R. | Neurath, M.

3

Risankizumab in patients with moderate to severe Crohn's disease : an open-label extension study

enthalten in: The lancet. Gastroenterology & hepatology | 2018

von Feagan, B. | Panés, J. | Ferrante, M. | +21

CommentIn: Lancet Gastroenterol Hepatol. 2018 Oct;3(10):656-657. - PMID 30056029

4

Induction therapy with the selective interleukin-23 inhibitor risankizumab in patients with moderate-to-severe Crohn's disease : a randomised, double-blind, placebo-controlled phase 2 study

enthalten in: Lancet (London, England) | 2017

von Feagan, B. | Sandborn, W. | D'Haens, G. | +19

CommentIn: Lancet. 2017 Apr 29;389(10080):1671-1672. - PMID 28411871

5

From bench to bedside : molecular imaging in inflammatory bowel diseases

enthalten in: Current opinion in gastroenterology | 2016

von Atreya, R. | Neurath, M.

6

Predicting Therapeutic Response by in vivo Molecular Imaging in Inflammatory Bowel Diseases

enthalten in: Digestive diseases (Basel, Switzerland) | 2016

von Atreya, R. | Neurath, M.

7

How will new and future therapies change our treatment of IBD?

enthalten in: Expert review of clinical immunology | 2016

von Zundler, S. | Neurath, M.

8

From physiology to disease and targeted therapy : interleukin-6 in inflammation and inflammation-associated carcinogenesis

enthalten in: Archives of toxicology | 2015

von Rath, T. | Billmeier, U. | Waldner, M. | +2

9

In vivo imaging using fluorescent antibodies to tumor necrosis factor predicts therapeutic response in Crohn's disease

enthalten in: Nature medicine | 2014

von Atreya, R. | Neumann, H. | Neufert, C. | +19

CommentIn: Gastroenterology. 2015 May;148(5):1067-9. - PMID 25824357

10

Infliximab treatment induces levels of the active azathioprine metabolite TGTP in Crohn's disease

enthalten in: Inflammatory bowel diseases | 2013

von Teichgräber, U. | Atreya, I. | Atreya, R. | +2